Atlas Trials

A Study of Real-world Treatment and Burden of Chronic Myeloid Leukemia Patients in Japan

Clinical trial NCT07150793 · COMPLETED

Trial details

NCT number
NCT07150793
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Study type
OBSERVATIONAL
Myeloid Leukemia, Chronic
Start date
2022-07-05
Primary completion
2023-02-08
Enrollment
754

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.